Literature DB >> 10670470

Motion VEPs, stereopsis, and bifoveal fusion in children with strabismus.

S L Fawcett1, E E Birch.   

Abstract

PURPOSE: The link between nasal-temporal motion asymmetries and anomalous binocular sensory function in infantile esotropia (ET) has led to the idea that visual evoked potential responses to horizontal motion (mVE) is an alternative measure of sensory binocularity to stereopsis. A second hypothesis is that the mVEP response is a marker for bifoveal fusion. The purpose of this study was to directly evaluate these two hypotheses by examining the correspondence between the mVEP response and both stereoacuity and bifoveal fusion in a cohort of strabismic patients with variable binocular sensory function.
METHODS: Motion VEPs, random dot stereopsis, and bifoveal fusion were measured in 94 children: 20 with infantile ET, 16 with infantile accommodative ET, 22 with late-onset accommodative ET, 10 with intermittent infantile strabismus, and 26 normal control participants.
RESULTS: Patients with infantile ET and infantile accommodative ET had high concordance between mVEP responses and stereoacuity and mVEP responses and bifoveal fusion. Asymmetric mVEP responses were highly concordant with both no measurable stereopsis and an absence of fusional vergence. Patients with late-onset accommodative ET and intermittent infantile strabismus revealed discordance between the mVEP response and stereoacuity and high concordance between the mVEP response and bifoveal fusion. Asymmetric mVEP responses were highly concordant with the absence of bifoveal fusion and the minimum-size prism to elicit fusional vergence.
CONCLUSIONS: The qualitative and quantitative relationship between the mVEP response and fusional vergence suggests that the mVEP response is an objective measure of bifoveal fusion. The availability of such a test will facilitate studies of normal development of bifoveal fusion and development of monofixation syndrome in strabismus.

Entities:  

Mesh:

Year:  2000        PMID: 10670470

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Fourier-analysed steady-state VEPs in pre-school children with and without normal binocularity.

Authors:  Björn Johansson; Peter Jakobsson
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

Review 2.  A primer on motion visual evoked potentials.

Authors:  Sven P Heinrich
Journal:  Doc Ophthalmol       Date:  2007-02-16       Impact factor: 2.379

3.  The decompensated monofixation syndrome (an American Ophthalmological Society thesis).

Authors:  R Michael Siatkowski
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

4.  Duration of binocular decorrelation in infancy predicts the severity of nasotemporal pursuit asymmetries in strabismic macaque monkeys.

Authors:  A Hasany; A Wong; P Foeller; D Bradley; L Tychsen
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

5.  Causing and curing infantile esotropia in primates: the role of decorrelated binocular input (an American Ophthalmological Society thesis).

Authors:  Lawrence Tychsen
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 6.  Timing of surgery for infantile esotropia: sensory and motor outcomes.

Authors:  Agnes M F Wong
Journal:  Can J Ophthalmol       Date:  2008-12       Impact factor: 1.882

7.  Improvement in motor development following surgery for infantile esotropia.

Authors:  James R Drover; David R Stager; Sarah E Morale; Joel N Leffler; Eileen E Birch
Journal:  J AAPOS       Date:  2007-12-21       Impact factor: 1.220

8.  Revisiting the functional significance of binocular cues for perceiving motion-in-depth.

Authors:  Peter J Kohler; Wesley J Meredith; Anthony M Norcia
Journal:  Nat Commun       Date:  2018-08-29       Impact factor: 14.919

9.  Simultaneous pattern visual evoked potential and pattern electroretinogram in strabismic and anisometropic amblyopia.

Authors:  J Heravian; R Daneshvar; F Dashti; A Azimi; H Ostadi Moghaddam; A A Yekta; H Esmaily
Journal:  Iran Red Crescent Med J       Date:  2011-01-01       Impact factor: 0.611

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.